Noxopharm Market Cap

Noxopharm has a market cap or net worth of 18.74 million as of March 9, 2026. Its market cap has decreased by -35.87% in one year.

Market Cap

18.74M

Enterprise Value

22.90M

Revenue

3.40M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.06

Market Cap Chart

Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 18.74M, an increase of 34.77%. That is a compound annual growth rate of 3.16%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	18.74M	-31.04%
Dec 31, 2025	27.18M	-
Dec 31, 2024	27.18M	30.99%
Dec 29, 2023	20.75M	-51.03%
Dec 30, 2022	42.37M	-62.82%
Dec 31, 2021	113.97M	-9.32%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Patrys	18.74M
Neurotech International	16.85M
Algorae Pharmaceuticals	23.98M
Argenica Therapeutics	28.26M
AdAlta	11.47M
Bio-Gene Technology	11.29M
NeuroScientific Biopharmaceuticals	32.26M
Tissue Repair	9.98M

Market Cap Rankings